Latest News in the pharma Industry

Research & Development

Lilly to Discontinue Development of Tabalumab

Lilly to Discontinue Development of Tabalumab

3 Oct 2014

Read more 
Two Phase III Studies Show Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol in Patients with Serious Genetic Disorders

Two Phase III Studies Show Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol in Patients with Serious Genetic Disorders

2 Oct 2014

Read more 
NIH Awards Seven New Vaccine Adjuvant Discovery Contracts

NIH Awards Seven New Vaccine Adjuvant Discovery Contracts

30 Sep 2014

Read more 
Genentech’s Investigational Combination of Cobimetinib Plus Zelboraf Provided Significant Benefit to People With Advanced Melanoma Over Zelboraf Alone

Genentech’s Investigational Combination of Cobimetinib Plus Zelboraf Provided Significant Benefit to People With Advanced Melanoma Over Zelboraf Alone

29 Sep 2014

Read more